Millipore Sigma Vibrant Logo

19-203 Epoxomicin Inhibitor

The Epoxomicin Inhibitor controls the biological activity of Epoxomicin. This small molecule/inhibitor is primarily used for Biochemicals applications.

Epoxomicin Inhibitor MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
View Products on Sigmaaldrich.com
19-203
100 µg  
가격 검색...
가격을 검색할 수 없습니다
Minimum Quantity needs to be mulitiple of
Maximum Quantity is
가격 문의 추가 정보
()이 할인됨
 
—
가격 문의
—
현재 재고 없음 현재 재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service

       

      고객 서비스로 문의

      개요

      Replacement Information
      Description
      Catalogue Number19-203
      Brand Family Upstate
      Trade Name
      • Upstate
      DescriptionEpoxomicin Inhibitor
      References
      Product Information
      Quality LevelMQ100
      Applications
      ApplicationThe Epoxomicin Inhibitor controls the biological activity of Epoxomicin. This small molecule/inhibitor is primarily used for Biochemicals applications.
      Key Applications
      • Inhibits Activity/Function
      Application NotesCell permeable, potent and specific irreversible inhibitor of the proteasome. Novel mechanism of action. Blocks chymotrypsin-like, trypsin like and PGPH activities of the proteasome. Regulates antigen presentation at non-toxic doses. Displays in vivo anti-inflammatory activity in mouse ear inflammation assay and in vitro NF-kB inhibition. The product is not sterile.
      Biological Information
      Entrez Gene Number
      Entrez Gene SummaryThis gene encodes ubiquitin, one of the most conserved proteins known. Ubiquitin is required for ATP-dependent, nonlysosomal intracellular protein degradation of abnormal proteins and normal proteins with a rapid turnover. Ubiquitin is covalently bound to proteins to be degraded, and presumably labels these proteins for degradation. Ubiquitin also binds to histone H2A in actively transcribed regions but does not cause histone H2A degradation, suggesting that ubiquitin is also involved in regulation of gene expression. This gene consists of three direct repeats of the ubiquitin coding sequence with no spacer sequence. Consequently, the protein is expressed as a polyubiquitin precursor with a final amino acid after the last repeat. Aberrant form of this protein has been noticed in patients with Alzheimer's and Down syndrome.
      Gene Symbol
      • RPS27A
      • CEP80
      • ubiquitin
      • ubiquitin-CEP80
      • UBCEP1
      • Ubiquitin.
      • UBA52
      • UBCEP2
      • UBA80
      • UBC
      • UBB
      • HUBCEP80
      Protein TargetRPS27A
      UniProt Number
      UniProt SummaryFUNCTION: SwissProt: P62988 # Protein modifier which can be covalently attached to target lysines either as a monomer or as a lysine-linked polymer. Attachment to proteins as a Lys-48-linked polymer usually leads to their degradation by proteasome. Attachment to proteins as a monomer or as an alternatively linked polymer does not lead to proteasomal degradation and may be required for numerous fonctions, including maintenance of chromatin structure, regulation of gene expression, stress response, ribosome biogenesis and DNA repair.
      SIZE: 76 amino acids; 8565 Da
      SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
      PTM: Several types of polymeric chains can be formed, depending on the lysine used for the assembly.
      SIMILARITY: SwissProt: P62988 ## Belongs to the ubiquitin family.
      MISCELLANEOUS: Ubiquitin is synthesized as a polyubiquitin precursor with exact head to tail repeats, the number of repeats differ between species and strains. In some species there is a final amino-acid after the last repeat, here in human a Val. Some ubiquitin genes contain a single copy of ubiquitin fused to a ribosomal protein (either L40 or S27a).
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStore at -20°C for up to 1 year. Store solutions at -20°C for up to 3 months.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      카탈로그 번호 GTIN
      19-203 04053252739439

      Documentation

      Epoxomicin Inhibitor MSDS

      타이틀

      물질안전보건자료(MSDS) 

      Epoxomicin Inhibitor Certificates of Analysis

      TitleLot Number
      Epoxomicin Inhibitor 3031646
      Epoxomicin Inhibitor - 2363007 2363007
      Epoxomicin Inhibitor - 2445897 2445897
      Epoxomicin Inhibitor - 0611045515 0611045515
      Epoxomicin Inhibitor - 2045850 2045850
      Epoxomicin Inhibitor - 2280887 2280887
      Epoxomicin Inhibitor - 2332571 2332571
      Epoxomicin Inhibitor - 3201588 3201588
      Epoxomicin Inhibitor - 3273583 3273583
      Epoxomicin Inhibitor - 3328192 3328192
      Show more

      References

      Reference overviewPub Med ID
      The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses
      Schwarz, K, et al
      J Immunol, 164:6147-6157 (2000)  2000

      		10843664 10843664
      Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
      Meng, L, et al
      Proc Natl Acad Sci USA, 96:10403-8 (1999)  1999

      		10468620 10468620